Article Text
Abstract
Background B-cells play a critical role in the regulation of systemic autoimmune diseases pathogenesis, that extends beyond antibodies production.
Objectives To examine B-cells subsets in peripheral blood of patients (pts) with untreated systemic lupus erythematosus (SLE). To analyze the association between B-cell subsets and disease-specific autoantibodies.
Methods Thirty six untreated SLE pts (31F/5M) were enrolled. SLE pts had median age of 37 years (range) (32–41), disease duration of 3.5 years (1–11), SLEDAI 2K of 7 (4–8), BILAG of 14,5 (10,2–23).
The control group consisted of 29 volunteers (23F/6M, median age 38 [35; 48] years). CD19+B cells, memory B cells (CD19+CD27+), switched memory B cells (CD19+ CD27+IgD-), non-switched memory B cells (CD19+CD27+ IgD+), naive (CD19+CD27-IgD+), double-negative (CD19+CD27-IgD-), transitional (CD19+CD38++CD10+IgD+CD27-) B cells, and plasmablasts (CD19+CD38+++CD27+IgD-CD20-) were analyzed using multicolor flow cytometry.
Results The absolute counts of memory B cells (CD19+CD27+), switched memory B cells (CD19+CD27+IgD-), transitional B cells (CD19+CD38++CD10+IgD+CD27-), and plasmablasts (CD19+CD38+++CD27+IgD-CD20-) were higher in untreated pts with SLE compared to healthy donors, p<0,01 for all cases. The absolute counts of double-negative B cells (CD19+CD27-IgD-) were lower in SLE pts than in donors, p=0,03 (Table 1).
At significant correlation was found in SLE pts between anti-dsDNA levels and absolute counts of the following B-cell subtypes: CD19+B cells (r=0,72), memory B cells (CD19+CD27+) (r=0,76), switched memory B cells (CD19+ CD27+IgD-) (r=0,75) and naive B cells (CD19+CD27-IgD+) (r=0,73), p<0,01 for all cases. In addition, in SLE pts the a-Sm levels correlated with absolute counts of the switched memory B cells (CD19+ CD27+IgD-) (r=0,98; (r=0,51, p<0,01), antibodies to cardiolipin (aCL) IgG levels with absolute counts of CD19+B cells (r=0,64, p=0,02), and with naive B cells (CD19+CD27-IgD+) (r=0,59, p=0,01).
Conclusions Immunophenotyping showed an increase in the absolute counts of memory B cells (CD19+CD27+), switched memory B cells (CD19+CD27+IgD-), transitional B cells (CD19+CD38++CD10+IgD+CD27-), and plasmablasts (CD19+CD38+++CD27+IgD-CD20-) in untreated SLE compared with healthy subjects. Positive correlation between the counts of B-cells subsets and values of disease-specific autoantibodies (anti-dsDNA, a-Sm, aCL IgG) suggests that B-lymphocytes may be involved in SLE pathogenesis.
This work was supported by the Russian Science Foundation (Grant N 22–25-00358).
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.